Dr. Franzmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1475 NW 12th Ave
Fl 1
Miami, FL 33136Phone+1 305-243-3564Fax+1 305-243-1283- Is this information wrong?
Summary
- Dr. Elizabeth Franzmann is an otolaryngologist in Miami, FL and is affiliated with multiple hospitals in the area, including Miami Veterans Affairs Healthcare System, University of Miami Hospital, and University of Miami Hospital and Clinics. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 22 years. She specializes in head & neck oncologic surgery and is experienced in head and neck oncology, head and neck oncology, head and neck neoplasms. Her research interests are in early detection of oral and oropharyngeal cancer.
Education & Training
- University of Miami/Jackson Health SystemResidency, Otolaryngology - Head and Neck Surgery, 2000 - 2002
- University of Miami/Jackson Health SystemInternship, Transitional Year, 1995 - 1996
- David Geffen School of Medicine at UCLAClass of 1995
Certifications & Licensure
- FL State Medical License 1997 - 2025
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Clinical Trials
- Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Start of enrollment: 2013 Jun 03
- A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia Start of enrollment: 2023 May 24
Roles: Contact, Sponsor-Investigator, Principal Investigator
- Safety and Efficacy of APG-157 in Head and Neck Cancer Start of enrollment: 2022 Apr 22
Publications & Presentations
PubMed
- 2 citationsThe Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma.Donald T Weed, Serena Zilio, Christie McGee, Boutheina Marnissi, Zoukaa Sargi, Elizabeth Franzmann, Giovana Thomas, Jason Leibowitz, Elizabeth Nicolli, David Arnold, S...> ;Cancer Research. 2023 Dec 1
- 3 citationsIndications and outcomes for elective dissection of level V in primary parotid cancer.Andrew P Katz, Riley Larkin, Erin R Cohen, Elizabeth Franzmann, Donald Weed, Francisco Civantos> ;Head & Neck. 2022 Jun 1
- Decreased Levels of Soluble CD44 in a High-Risk Population following a Smoking Cessation Program.Drew H Smith, Shahm Raslan, Isildinha M Reis, Abdurrahman Al-Awady, Isabella Buitron, Melanie Perez, Huaping Liu, Jerri Halgowich, Claudia Gordon, Monica Webb Hooper, ...> ;International Journal of Environmental Research and Public Health. 2021 Dec 14
- Join now to see all
Press Mentions
- COVID-19 Vaccine Trials Exhibit Early SuccessNovember 23rd, 2020
- Vigilant Biosciences Announces Multiple Poster Presentations in Support of OncAlert® Oral Cancer and OncAlert Labs Product LinesMarch 22nd, 2017
- Sylvester’s Game Changer Vehicles Bring Free Cancer Screenings to Underserved South Florida CommunitiesAugust 25th, 2023
Grant Support
- Salivary Soluble Markers In Head And Neck CancerNational Cancer Institute2007–2010
- Salivary Soluble CD44: A Molecular Marker For Head And *National Cancer Institute2005
- Salivary Soluble CD44: A Molecular Marker For HnsccNational Cancer Institute2004
Professional Memberships
- Fellow
- Member
Hospital Affiliations
- Miami Veterans Affairs Healthcare SystemMiami, Florida
- University of Miami HospitalMiami, Florida
- UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Industry Relationships
- Scientific Founder, Vigilant Biosciences
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: